Drug-Drug Interaction Potential of Remimazolam Mediated by CYP 450, Transporters, and Protein Binding.

Karl-Uwe PetersenWolfgang SchmalixMarija PesicThomas Stöhr

Published in: Current drug metabolism (2024)

The present data and analyses suggest a very low potential of remimazolam for pharmacoki-netic DDIs mediated by CYP isoforms, drug transporters, and protein binding.

Keyphrases

binding protein
protein protein
adverse drug
human health
drug induced
dna binding
emergency department
amino acid
electronic health record
small molecule
risk assessment
machine learning